Solana's Revenue in the fiscal year 2025 $ 6.02 millions
Solana's Revenue in the fiscal year 2024 $ 0.52 millions
Solana's Revenue in the fiscal year 2023 $ 0.64 millions
Solana's Revenue in the fiscal year 2022 $ 0.79 millions
Solana's Revenue in the fiscal year 2021 $ 0.52 millions
HSDT Revenue third quarter 2026 Y/Y Growth Comment
Solana Company achieved in the third quarter 2026, above Company average Revenue surge of 8300% year on year, to $ 3.36 millions.
According to the results reported in the third quarter 2026, Solana Company achieved the best Revenue growth in Medical Equipment & Supplies industry. While Solana Company' s Revenue doubling of 8300% ranks overall at the positon no. 19 in the third quarter 2026.
Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026
Solana's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
1520.93 %
89.88 %
-73.38 %
(Sep 30 2025)
HSDT's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2026 Solana Company disclosed drop in Revenue from the second quarter by -7.18% to $ 3.36 millions, from $ 3.62 millions achived in the previous reporting period.
But that's not important problem, as Solana's Revenue generally seem to plunge in this quarter.
Within Medical Equipment & Supplies industry 133 other companies have achieved higher Revenue quarter on quarter growth. While Solana's Revenue growth quarter on quarter, overall rank is 2951.
In the III. Quarter 2026 Solana Company disclosed drop in Revenue from the second quarter by -7.18% to $ 3.36 millions, from $ 3.62 millions achived in the previous reporting period.
But that's not important problem, as Solana's Revenue generally seem to plunge in this quarter.
Within Medical Equipment & Supplies industry 133 other companies have achieved higher Revenue quarter on quarter growth. While Solana's Revenue growth quarter on quarter, overall rank is 2951.
Solana saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 4274.92% year on year, to $ 13 millions if the fiscal year would have ended in Sep 30 2026. Solana's trailing twelve months Revenue growth was higher than company's average 141.72% and higher than 2109.45% growth in Mar 31 2026. But from twelve months ended Mar 31 2026 rise was beneth at 34.59 % from $9.59 millions achieved in the period from Mar 31 2026 to Jun 30 2025. We witness drop-off happening, more obvious observing the When you usual Q/Q TTM historic rise that is stronger at141.72%.
In the Healthcare sector 422 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2894 to 2918.
Solana saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 4274.92% year on year, to $ 13 millions if the fiscal year would have ended in Sep 30 2026. Solana's trailing twelve months Revenue growth was higher than company's average 141.72% and higher than 2109.45% growth in Mar 31 2026. But from twelve months ended Mar 31 2026 rise was beneth at 34.59 % from $9.59 millions achieved in the period from Mar 31 2026 to Jun 30 2025. We witness drop-off happening, more obvious observing the When you usual Q/Q TTM historic rise that is stronger at141.72%. The momentum is even more impressive from twelve months ended Mar 31 2026 exhibited at 34.59 % increase from $9.59 millions in the period from Mar 31 2026 to Jun 30 2025.
In the Healthcare sector 422 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2894 to 2918.
About Solana Revenue Growth Rates (HSDT), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
5,723.64%